All Products

Cat.No.

Product Name / Activity

Antibody recognizing M₁

Antibody recognizing MAO-A

Antibody recognizing MAO-B

Antibody recognizing MC₂

Antibody recognizing MC₃

Antibody recognizing rat mGlu₂

Antibody recognizing rat mGlu₅

Antibody recognizing human mGlu₇

Antibody recognizing MMP-7

Antibody recognizing MDM2 phosphorylated at Ser¹⁸⁶

Potent and selective GAL₂ agonist

Histone deacetylase inhibitor

Phospholipase C activator

Inactive analog of m-3M3FBS (Cat. No. 1941)

Potent, non-selective galanin receptor antagonist

Selective GAL₁ agonist

Selective GAL₂ antagonist

Hsp90 inhibitor

Potent, irreversible FAAH inhibitor

Oxidative phosphorylation uncoupler

Potent group II mGlu agonist. Also specific group III mGlu antagonist

Selection of 5 MAPK cascade inhibitors (Cat. Nos. 1110, 1213, 1321, 1144 and 1202)

Selection of 5 MAPK inhibitors (Cat. Nos 1213, 1202, 1264, 1496 and 1144)

Noradrenalin re-uptake inhibitor

Broad spectrum MMP inhibitor

Activates G_i and G_o

G protein activator peptide

Potent, selective mGlu₁ antagonist

Protein kinase C inhibitor

Protein kinase C inhibitor

Potent endogenous MCH agonist

Potent, MCH receptor agonist

Selective MC₄ receptor antagonist

Potent, orally active 5-HT uptake inhibitor. Also inhibits noradrenalin and dopamine uptake in vitro

Selective M₁ muscarinic agonist

Non-selective mGlu antagonist

Non-selective mGlu antagonist. Active isomer of Cat. No. 0336

5-HT_2A antagonist

Potent, selective calpain and cathepsin B inhibitor

Selective NK₂ antagonist

5-HT₃ antagonist

Polyamine oxidase (PAO) inhibitor

Potent 5-HT_1A ligand

Potent and selective 5-HT_1A partial agonist

Inhibitor of 5-HT and dopamine uptake; hallucinogenic

Non-competitive nicotinic receptor antagonist

Very selective and potent A₁ receptor agonist

Potent, highly selective α₂ agonist

Selection of 3 MEK inhibitors (Cat. Nos. 1213, 1969 and 1144)

Inhibitor of α-MSH release; inhibits opioid effects in vivo

High affinity melanocortin receptor agonist

Endogenous hormone; agonist at MT₁ and MT₂

Inhibits G_s and stimulates G_i activity

5-HT_2A/D₂ receptor antagonist; neuroleptic

NMDA antagonist, acts ion channel site

Potent, selective NK₂ antagonist

Potent, selective NK₂ antagonist

CYP2C19 substrate. Anticonvulsant

μ₁ partial agonist

Selective H₁ inverse agonist

Orally active PDE4 inhibitor

Acylator of PCP and σ receptors

Potent, endogenous ligand for KISS1 receptor (hOT7T175/AXOR12/GPR54)

5-HT₂ antagonist. Also 5-HT₁ antagonist and 5-HT_1D ligand. Has moderate affinity for 5-HT₆ and high affinity for 5-HT₇

Activator of LKB1/AMPK; antidiabetic agent

Potent and selective CB₁ agonist

Potent and selective CB₁ agonist (in water-soluble emulsion)

Extremely selective H₃ agonist

Has moderate affinity for 5-ht₅ and high affinity for 5-ht₆ and 5-HT₇. Also antagonist at 5-HT₁ and 5-HT₂

Cytotoxic agent

Apoptotic and antiangiogenic agent

EGFR-kinase inhibitor

Aromatic L-amino acid decarboxylase inhibitor

Biological stain

P2 agonist

Active metabolite of methysergide

Potent muscarinic agonist

Activator of GABA amino-transferase

EAAT2 and EAAT4 blocker

Potent, standard H₃ agonist

H₃ agonist, less active enantiomer

Selective, high affinity H₄ agonist

Non-selective H₃ agonist

5-HT₃ agonist/potent 5-HT₆ ligand

5-HT_2B agonist

Highly selective iNOS inhibitor

Lysosomal system c L-arginine uptake inhibitor

Enhances biosynthesis of phosphatidylinositol

α7 neuronal nicotinic receptor antagonist

Inhibitor of dopamine and noradrenalin transporters. Psychomotor stimulant

Potent and selective 5-HT_2C agonist

5-HT₃ agonist

Potent agonist for P2Y₁, P2Y₁₂ and P2Y₁₃

P2 purinergic agonist

5-HT₁/5-HT₂ antagonist

Selective β₁ antagonist

11-β hydroxylase inhibitor

HMG-CoA reductase inhibitor

Na⁺ channel blocker, antiarrhythmic agent

Calpain inhibitor; activates p53-dependent apoptosis

Proteasome and calpain inhibitor. Inhibits NF-κB activation

α7 neuronal nicotinic receptor antagonist

Blocking peptide for anti-mGlu₂ (Cat. No. 2027)

Blocking peptide for anti-mGlu₅ (Cat. No. 2032)

Blocking peptide for anti-mGlu₇ (Cat. No. 2031)

5-HT₂ antagonist. Has moderate affinity for 5-ht₆

Ca²⁺ channel blocker (T-type)

Antifungal agent

Benzodiazepine agonist

Progesterone and glucocorticoid antagonist

Ceramide-specific glycosyltransferase inhibitor. Also inhibits α-glucosidase I and II

Muscarinic receptor agonist

5-HT and noradrenalin re-uptake inhibitor (SNRI)

PDE3 inhibitor

K⁺ channel (K_ATP) opener

Restores mutant p53 activity; proapoptotic

MRN-ATM pathway inhibitor

Potent 5-HT₂ antagonist. Also 5-HT₃, H₁ and α₂-antagonist. Antidepressant

Cytoprotective PGE₁ analog

Inhibitor of DNA and RNA polymerase

DNA cross-linking antitumor agent

Selection of 5 mixed adrenoceptor ligands (Cat. Nos. 0888, 0425, 1747, 0623 and 0952)

Selection of 5 mixed kinase inhibitors (Cat. Nos. 0741, 1277, 1288, 1289 and 1285)

Selection of 5 mixed mGlu receptor ligands (Cat. Nos. 0805, 0975, 0103, 0337 and 1209)

Selection of 5 mixed NMDA receptor ligands (Cat. Nos. 0114, 0312, 0106, 0924 and 1241)

5-HT_2C agonist

Potent CysLT₁ (LTD₄) inverse agonist. Also MRP inhibitor

NMDA antagonist, less active enantiomer

Non-competitive NMDA antagonist, acts at ion channel site

Inhibitor of 5-lipoxygenase-activating protein (FLAP)

Potent and selective 5-HT₄ partial agonist

Myosin light chain kinase inhibitor

Myosin light chain kinase inhibitor

Selective inhibitor of myosin light chain kinase

5-HT_1A (postsynaptic) antagonist

Potent and selective FPR2 agonist

Potent, allosteric mGlu₇-selective antagonist

PDE1 inhibitor

Caged NMDA

Stable photoreleaser of L-glutamate

Caged D-aspartate; NMDA agonist

Immunosuppressant

Selective inhibitor of Src and Syk

Psychostimulant

Angiotensin-converting enzyme (ACE) inhibitor

Encephalitogenic myelin oligodendrocyte glycoprotein fragment

Selective inhibitor of mitotic kinesin Eg5

5-HT₄ agonist and 5-HT₃ antagonist

Endogenous peptide regulator of gastrointestinal motility

I₁ receptor and α₂-adrenoceptor agonist (I₁ > α₂)

Potent inhibitor of L-glutamate uptake. Less activity as a substrate compared to its parent compound (Cat. No. 0298)

Melatonin agonist

mGlu₅ antagonist and positive allosteric modulator at mGlu₄

Potent, selective α₁ antagonist. Also σ₂ ligand

Highly selective ERα antagonist

Group III/group II mGlu antagonist. More selective for group III than group II

α₁ ligand

Selective κ agonist

Stimulates ACh release

Highly potent, selective hA₃ antagonist

Potent, highly selective hA₃ antagonist

Potent and selective A_2B inverse agonist

Selective A_2B antagonist

Potent SOC inhibitor; blocks capacitative Ca²⁺ entry

Selective P2Y₁ antagonist

Competitive P2Y₁₃ antagonist

Potentiates P2X₁-mediated responses

Selective, high affinity P2Y₁ antagonist

Highly potent and selective P2Y₁ agonist

Extremely potent and selective P2Y₁ antagonist

Selective P2Y₆ antagonist

Potent P2Y₁₄ agonist

High affinity, selective A₃ antagonist

Selective MC₃ receptor agonist

Endogenous melanocortin receptor agonist

Melanocortin receptor agonist

Specific group III mGlu antagonist

Group II/group III mGlu antagonist

Potent, selective mGlu₅ antagonist

Group II/group III mGlu antagonist. More selective for group II than group III

Potent GABA_A agonist

PDE5 inhibitor

Inosine monophosphatase dehydrogenase inhibitor

Major antigenic component implicated in the pathophysiology of multiple sclerosis

Intermediate in lipid metabolism